Paradigm Medical Industries, Inc. (PDMI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2011 | 525 Thousand USD | 26.51% |
| 2010 | 415 Thousand USD | -7.78% |
| 2009 | 450 Thousand USD | -18.92% |
| 2008 | 555 Thousand USD | -34.86% |
| 2007 | 852 Thousand USD | -7.19% |
| 2006 | 918 Thousand USD | 52.49% |
| 2005 | 602 Thousand USD | -67.37% |
| 2004 | 1.84 Million USD | 89.62% |
| 2003 | 973 Thousand USD | -15.98% |
| 2002 | 1.15 Million USD | -61.49% |
| 2001 | 3 Million USD | 59.02% |
| 2000 | 1.89 Million USD | 89.1% |
| 1999 | 1 Million USD | 66.67% |
| 1998 | 600 Thousand USD | 50.0% |
| 1997 | 400 Thousand USD | 100.0% |
| 1996 | 200 Thousand USD | 0.0% |
| 1995 | 200 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2011 FY | 525 Thousand USD | 26.51% |
| 2010 FY | 415 Thousand USD | -7.78% |
| 2009 Q1 | 82 Thousand USD | -49.07% |
| 2009 FY | 450 Thousand USD | -18.92% |
| 2008 FY | 555 Thousand USD | -34.86% |
| 2008 Q1 | 87 Thousand USD | -71.66% |
| 2008 Q4 | 161 Thousand USD | -25.12% |
| 2008 Q3 | 215 Thousand USD | 136.26% |
| 2008 Q2 | 91 Thousand USD | 4.6% |
| 2007 FY | 852 Thousand USD | -7.19% |
| 2007 Q4 | 307 Thousand USD | 16.29% |
| 2007 Q2 | 111 Thousand USD | -35.47% |
| 2007 Q1 | 172 Thousand USD | 8.18% |
| 2007 Q3 | 264 Thousand USD | 137.84% |
| 2006 Q4 | 159 Thousand USD | -26.05% |
| 2006 Q2 | 302 Thousand USD | 25.31% |
| 2006 FY | 918 Thousand USD | 52.49% |
| 2006 Q1 | 241 Thousand USD | 156.57% |
| 2006 Q3 | 215 Thousand USD | -28.81% |
| 2005 Q4 | -426 Thousand USD | -238.31% |
| 2005 FY | 602 Thousand USD | -67.37% |
| 2005 Q2 | 407 Thousand USD | 29.62% |
| 2005 Q3 | 308 Thousand USD | -24.32% |
| 2005 Q1 | 314 Thousand USD | -24.52% |
| 2004 FY | 1.84 Million USD | 89.62% |
| 2004 Q4 | 416 Thousand USD | -23.11% |
| 2004 Q3 | 541 Thousand USD | 1.5% |
| 2004 Q2 | 533 Thousand USD | 49.72% |
| 2004 Q1 | 356 Thousand USD | 2473.33% |
| 2003 Q1 | 381 Thousand USD | 176.51% |
| 2003 FY | 973 Thousand USD | -15.98% |
| 2003 Q4 | -15 Thousand USD | -103.01% |
| 2003 Q3 | 499 Thousand USD | 366.36% |
| 2003 Q2 | 107 Thousand USD | -71.92% |
| 2002 Q2 | 498 Thousand USD | -28.45% |
| 2002 Q3 | 462 Thousand USD | -7.23% |
| 2002 FY | 1.15 Million USD | -61.49% |
| 2002 Q4 | -498 Thousand USD | -207.79% |
| 2002 Q1 | 696 Thousand USD | -28.54% |
| 2001 Q4 | 974 Thousand USD | 34.9% |
| 2001 FY | 3 Million USD | 59.02% |
| 2001 Q3 | 722 Thousand USD | -2.43% |
| 2001 Q2 | 740 Thousand USD | 19.16% |
| 2001 Q1 | 621 Thousand USD | 465.29% |
| 2000 Q4 | -170 Thousand USD | -144.39% |
| 2000 FY | 1.89 Million USD | 89.1% |
| 2000 Q1 | 553 Thousand USD | 38.25% |
| 2000 Q2 | 774 Thousand USD | 39.96% |
| 2000 Q3 | 383 Thousand USD | -50.52% |
| 1999 Q1 | - USD | -100.0% |
| 1999 Q4 | 400 Thousand USD | 0.0% |
| 1999 Q2 | 600 Thousand USD | 0.0% |
| 1999 FY | 1 Million USD | 66.67% |
| 1999 Q3 | - USD | -100.0% |
| 1998 FY | 600 Thousand USD | 50.0% |
| 1998 Q4 | 100 Thousand USD | 0.0% |
| 1998 Q3 | 100 Thousand USD | -75.0% |
| 1998 Q2 | 400 Thousand USD | 100.0% |
| 1998 Q1 | 200 Thousand USD | -33.33% |
| 1997 Q1 | 600 Thousand USD | 500.0% |
| 1997 Q4 | 300 Thousand USD | 200.0% |
| 1997 Q3 | 100 Thousand USD | 133.33% |
| 1997 FY | 400 Thousand USD | 100.0% |
| 1997 Q2 | -300 Thousand USD | -150.0% |
| 1996 Q3 | - USD | -100.0% |
| 1996 Q1 | 100 Thousand USD | 0.0% |
| 1996 FY | 200 Thousand USD | 0.0% |
| 1996 Q2 | 100 Thousand USD | 0.0% |
| 1996 Q4 | 100 Thousand USD | 0.0% |
| 1995 Q4 | 100 Thousand USD | 0.0% |
| 1995 Q1 | 100 Thousand USD | 0.0% |
| 1995 FY | 200 Thousand USD | 0.0% |
| 1995 Q2 | 100 Thousand USD | 0.0% |
| 1995 Q3 | 100 Thousand USD | 0.0% |
| 1994 Q4 | 100 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | 69.101% |
| Ansell Limited | 624.8 Million USD | 99.916% |
| Ansell Limited | 624.8 Million USD | 99.916% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 113.94 Million USD | 99.539% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -288.731% |
| Psykey, Inc. | 415.97 Thousand USD | -26.209% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.956% |
| ConvaTec Group Plc | 1.17 Billion USD | 99.955% |
| Encision Inc. | 3.13 Million USD | 83.259% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 794.01 Thousand USD | 33.88% |
| LifePoint, Inc. | -71.35 Thousand USD | 835.727% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 500.763% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 603.24 Thousand USD | 12.97% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | 11.975% |
| SmileDirectClub, Inc. | 275.84 Million USD | 99.81% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | 99.942% |
| SheerVision, Inc. | 2.17 Million USD | 75.872% |
| United Health Products, Inc. | -4857.00 USD | 10909.141% |
| Vasamed, Inc. | -69.38 Thousand USD | 856.615% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | -96.142% |
| Yubo International Biotech Limited | 52.65 Thousand USD | -897.113% |